Policymakers used to think nothing could keep ex-convicts from returning to prison. Welfare reform changed that.
It’s America’s largest and most endangered health insurance program. Changes that give consumers more say—like the new Part D drug benefit—are helpful, but we’ll have to make tough trade-offs in the years ahead.
Blackstone's plans would create a new kind of public firm.
The Global Fund will only be as effective as its procurement process allows.
French opposition to the Louvre’s deal with Abu Dhabi is hypocritical.
What’s really been happening since Hurricane Katrina? Tom Bethell, dismayed by media coverage, traveled back to the beautiful and tragic city where he once lived for a firsthand view. He found this story of rebirth.
A bill pending in the House shows that neither party can resist.
As they construct a truly three-dimensional cyberspace, people are starting to make real money.
The FDA banned silicone implants in 1992 despite a lack of evidence that they were unsafe. Now, the ban has been reversed Where’s the apology? asks Amity Shlaes. Where do the shareholders go to get their equity back?
AEI's resident Vioxx expert brings us up to date.
The rhetoric of consumer protection has gone way, way overboard.
A new book takes readers inside Monopoly’s surprising history.
An accessible book explores the brave new world of mass collaboration.
The company’s capitulation to federal regulators is less significant than you think.
The Kremlin’s Public Relations Problem
Why the trade deficit is less of a problem than you think.
At the stroke of midnight on July 1, 1997, China took over Hong Kong from the British, and fears of economic and political decline were rife. Today, Hong Kong remains number one in the global rankings, and, by some measures, it’s a better place to do business than ever. John Fund tells why.